• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Impact of Personalized Medicine on Treatment Decisions

Video

“We evaluate personalized medicine regimes that include lab testing, a scoring system, and other factors associated with the patient,” according to Edmund Pezalla, MD, MPH.

Pezalla explained that personalized medicine is evaluated based on whether the treatments have demonstrated better outcomes or if it is clear that they will alter clinical decisions. He emphasized that just an add-on test is of no value, so diagnostics that expect clinical integration should impact outcomes.

“Companion diagnostics are enormous in this area because they help make a choice for or against a drug and using it to choose a particular pathway. [These diagnostics] measure something that can be acted on,” Pezalla said.


Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.